Gefitinib is primarily used for the management of non-small cell lung cancer (NSCLC), especially in patients who have certain types of epidermal growth factor receptor mutations. It belongs to the group of anti-cancer medicines known as tyrosine kinase inhibitors.
In addition to its main use, it's also indicated for locally advanced or metastatic NSCLC in patients who have activating mutations of epidermal growth factor receptor tyrosine kinase (EGFR-TK).
Diarrhoea
Skin rash
Dry skin
Nausea
Vomiting
Gefitinib is an anti-cancer medication.
It works by blocking the protein called Epidermal Growth Factor Receptor (EGFR) that signals cancer cells to grow and divide. Specifically, it inhibits the activity of the EGFR-Tyrosine Kinase enzyme, a subtype of EGFR, thereby suppressing the development and spread of cancer cells.
Additionally, Gefitinib also inhibits other cellular signalling pathways associated with insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF), which further helps in controlling the proliferation of cancer cells. This targeted action makes Gefitinib particularly effective in managing non-small cell lung cancer in patients who have certain mutations in their EGFR genes.
Doctor of Medicine
BMS, FMC, MD Resident
Gefitinib is available in the form of oral tablets.
Gefitinib is meant for adult patients only.
Gefitinib is contraindicated in patients with hypersensitivity to the medicine or any of its inactive ingredients.
It should be used cautiously in patients with liver disease and severe renal impairment.
Gefitinib may interact with medicines that induce CYP3A4 activity (e.g., phenytoin and rifampin) and those that inhibit CYP3A4 activity (e.g., itraconazole and ketoconazole).
Also, medicines that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or cimetidine) may interact with Gefitinib.
An overdose of Gefitinib may increase the severity of the side effects, such as diarrhoea and skin rash. If this occurs, get medical help immediately.
If you miss a dose of Gefitinib, take it as soon as you remember, unless it is nearly time for your next dose. In that case, skip the missed dose and continue with your regular schedule.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
If you experience skin reactions like rash or acne, avoid direct exposure to sunlight. Use sunscreen if necessary.
Drink plenty of water if you experience diarrhoea or nausea to avoid dehydration.
Gefitinib may cause side effects like dizziness or blurred vision, which may affect your ability to drive or operate heavy machinery.
Avoid driving or operating machinery if you experience any of these side effects.
Gefitinib is not recommended during pregnancy unless it is considered essential by your doctor due to potential risk to the foetus.
It is not known whether Gefitinib passes into breast milk. Therefore, breastfeeding mothers should consult their doctor before using this medicine.
Patients with liver disease or renal impairment should exercise caution when taking Gefitinib.
It is recommended that patients with lung disorders such as interstitial lung disease (ILD) should be closely monitored for pulmonary symptoms while on treatment with Gefitinib.
Aim to maintain a balanced diet with plenty of fruits and vegetables to support your immune system while on treatment with Gefitinib.
Avoid smoking and alcohol consumption, as they may increase the risk of lung disease and liver damage.
Regular physical activity can help manage stress and improve overall health. However, be sure to discuss the type and level of physical activity that is suitable for you with your doctor.
Ensure adequate hydration, particularly if experiencing side effects like diarrhoea or vomiting.
Frequently asked questions
No, Gefitinib is not a steroid. It belongs to the class of anti-cancer medications known as tyrosine kinase inhibitors.
There is no specific mention in the research data about Gefitinib affecting sleep. If you observe such an effect, it is best to consult your doctor.
Yes. The recommended dosage of Gefitinib is 250 mg orally once daily until disease progression or unacceptable toxicity, as per your doctor's advice.
Gefitinib begins working soon after administration by blocking certain enzymes that promote cancer cell growth and survival. However, the time it takes to see a noticeable improvement in health conditions can vary among individuals.
Gefitinib can be taken at any time of the day as long as it is consumed at around the same time daily, which aids in maintaining a constant level of medication in the body.
The duration of treatment with Gefitinib varies depending on the patient's medical condition and response to therapy. It will be determined by your doctor.
Gefitinib is a prescription medication and is not available over the counter. It must be used under the supervision of a doctor.
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.16
Our Payment Partners